Sofie Meulewaeter

Academic, Basic (bio-) Medical Sciences

Laarbeeklaan 103
1090 Brussels
Belgium

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Sofie Meulewaeter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

7 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

1 Poster

Nanobody-mediated imaging of PD-L1 provides a rationale to combine Galsome vaccination with immune checkpoint blockade
Ertveldt, T., Meulewaeter, S., Lentacker, I., Verbeke, R., De Smedt, S., Olarte, O., Barbé, K., Keyaerts, M., Dewitte, H. & Breckpot, K., 7 Feb 2020, p. 1. 1 p.
Research output: Unpublished contribution to conference › Poster

1 Talk or presentation at a workshop/seminar

Nanobody-mediated molecular imaging provides spatiotemporal insight in mRNA-vaccine-induced PD-L1 upregulation
Thomas Ertveldt (Speaker), Sofie Meulewaeter (Speaker), Ine Lentacker (Contributor), Rein Verbeke (Contributor), Stefaan De Smedt (Contributor), Oscar Javier Olarte Rodriguez (Contributor), Kurt Barbé (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Heleen Dewitte (Contributor), Karine Breckpot (Contributor)
19 Apr 2021
Activity: Talk or presentation › Talk or presentation at a workshop/seminar

Nanobody-mediated imaging of PD-L1 provides a rationale to combine Galsome vaccination with immune checkpoint blockade

Nanobody-mediated molecular imaging provides spatiotemporal insight in mRNA-vaccine-induced PD-L1 upregulation